REGULATION OF PROCOLLAGEN METABOLISM IN THE PRESSURE-OVERLOADED RAT-HEART

被引:60
|
作者
ELEFTHERIADES, EG
DURAND, JB
FERGUSON, AG
ENGELMANN, GL
JONES, SB
SAMAREL, AM
机构
[1] LOYOLA UNIV,STRITCH SCH MED,MED CTR,DEPT MED,2160 S 1ST AVE,MAYWOOD,IL 60153
[2] LOYOLA UNIV,STRITCH SCH MED,MED CTR,DEPT PHYSIOL,MAYWOOD,IL 60153
关键词
EXTRACELLULAR MATRIX; FIBROSIS; HYPERTENSION; HYPERTROPHY; GENE EXPRESSION;
D O I
10.1172/JCI116270
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To determine the molecular events responsible for the disproportionate accumulation of myocardial fibrillar collagens during sustained hypertension, we examined the in vivo rate of procollagen synthesis, collagen accumulation, and intracellular procollagen degradation 1-16 wk after abdominal aortic banding in young rats. These measurements were correlated with tissue mRNA levels for type I and type III procollagen polypeptides. Banded animals developed moderate, sustained hypertension and mild left ventricular hypertrophy. Increased type III procollagen mRNA levels were detected early after banding and persisted for the entire observation period. Disproportionate collagen accumulation without histological evidence of fibrosis was noted within 1 wk after hypertension induction. Fibrillar collagen accumulation at this time point resulted not from a major increase in procollagen synthesis, but rather a marked decrease in the rate of intracellular procollagen degradation. Interstitial fibrosis, however, was observed 16 wk after banding. Type I procollagen mRNA levels were increased six-fold, but only after 16 wk of hypertension. These results correlated well with the results of in vivo procollagen synthesis experiments at 16 wk, which demonstrated a threefold increase in left ventricular procollagen biosynthesis. We conclude that pretranslational as well as posttranslational mechanisms regulate fibrillar collagen deposition in the myocardial extracellular matrix during sustained hypertension.
引用
收藏
页码:1113 / 1122
页数:10
相关论文
共 50 条
  • [21] In vivo transfer of a β2-adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to β-adrenergic agonist
    Kawahira, Y
    Sawa, Y
    Nishimura, M
    Sakakida, S
    Ueda, H
    Kaneda, Y
    Matsuda, H
    CIRCULATION, 1998, 98 (19) : II262 - II267
  • [22] Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium
    Harston, Rebecca K.
    McKillop, John C.
    Moschella, Phillip C.
    Van Laer, An
    Quinones, Lakeya S.
    Baicu, Catalin F.
    Balasubramanian, Sundaravadivel
    Zile, Michael R.
    Kuppuswamy, Dhandapani
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (05): : H1696 - H1706
  • [23] Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart
    Sugano, Yasuo
    Lai, N. Chin
    Gao, Mei Hua
    Firth, Amy L.
    Yuan, Jason X-J
    Lew, Wilbur Y. W.
    Hammond, H. Kirk
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 405 (03) : 349 - 355
  • [24] Left ventricular wall stress normalization in chronic pressure-overloaded heart: a mathematical model study
    Segers, P
    Stergiopulos, N
    Schreuder, JJ
    Westerhof, BE
    Westerhof, N
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (03): : H1120 - H1127
  • [25] Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan
    Mutsumi Iwamoto
    Satoshi Hirohata
    Hiroko Ogawa
    Takashi Ohtsuki
    Ryoko Shinohata
    Toru Miyoshi
    Faruk O Hatipoglu
    Shozo Kusachi
    Kazuhide Yamamoto
    Yoshifumi Ninomiya
    Hypertension Research, 2010, 33 : 1305 - 1311
  • [26] Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice
    Ogita, H
    Node, K
    Liao, YL
    Ishikura, F
    Beppu, S
    Asanuma, H
    Sanada, S
    Takashima, S
    Minamino, T
    Hori, M
    Kitakaze, M
    HYPERTENSION, 2004, 43 (02) : 237 - 242
  • [27] Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart
    Furukawa, Nozomi
    Koitabashi, Norimichi
    Sunaga, Hiroaki
    Obokata, Masaru
    Umbarawan, Yogi
    Syamsunarno, Mas R.
    Yamaguchi, Aiko
    Matsui, Hiroki
    Yokoyama, Tomoyuki
    Kurabayashi, Masahiko
    CIRCULATION, 2016, 134
  • [28] Stop Me at Your Own PeRiL: PRL2 Constrains AMPK in the Pressure-Overloaded Heart
    Bertero, Edoardo
    Ghigo, Alessandra
    Ameri, Pietro
    CIRCULATION RESEARCH, 2025, 136 (07) : 664 - 666
  • [29] Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart
    Furukawa, Nozomi
    Koitabashi, Norimichi
    Sunaga, Hiroaki
    Obokata, Masaru
    Umbarawan, Yogi
    Syamsunarno, Mas R.
    Yamaguchi, Aiko
    Matsui, Hiroki
    Yokoyama, Tomoyuki
    Kurabayashi, Masahiko
    CIRCULATION, 2016, 134
  • [30] Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan
    Iwamoto, Mutsumi
    Hirohata, Satoshi
    Ogawa, Hiroko
    Ohtsuki, Takashi
    Shinohata, Ryoko
    Miyoshi, Toru
    Hatipoglu, O. Faruk
    Kusachi, Shozo
    Yamamoto, Kazuhide
    Ninomiya, Yoshifumi
    HYPERTENSION RESEARCH, 2010, 33 (12) : 1305 - 1311